We are thrilled to announce that our Vice President of Medicinal Chemistry, Rick Ewing, has achieved not one, but two prestigious awards that recognize his outstanding contributions to the field of chemistry and innovation. These honors are a testament to his dedication, expertise, and unwavering commitment to advancing the boundaries of science.
1. 2023 Edison Patent Award in Biotechnology: Rick Ewing has been selected as the recipient of the 2023 Edison Patent Award in Biotechnology. This coveted award, a team honor, acknowledges his exemplary work in collaboration with the Scripps Institute and Bristol Myers Squibb. The accolade is presented in recognition of the most patents for innovation with a tangible commercial impact.
Award Details:
- Date: November 15th, 2023
- Presentation: Rick Ewing will be honored at a prestigious ceremony where he will also deliver a lecture, sharing insights into the groundbreaking work that led to this achievement. The patent named is Phosphorous (V)-Based Reagents, Processes for the Preparation Thereof, and Their Use in Making Stereo-Defined Organophosphorous (V) Compounds, U.S. Patent 11,613,554
This award underscores Rick’s pivotal role in pushing the boundaries of biotechnology and his unparalleled contributions to our organization’s innovative endeavors.
2. 2023 American Chemical Society, Philadelphia Section Award: Rick Ewing has also been selected to receive the 2023 American Chemical Society (ACS) Philadelphia Section Award, the highest accolade offered by this renowned organization. This award celebrates distinguished careers in the chemical sciences and is typically bestowed upon academic professors or industrial chemists who have demonstrated unparalleled excellence in their field.
Award Details:
- Date: November 14th, 2023
- Recognition: Rick will be honored for his remarkable contributions to the chemical sciences, a testament to his unparalleled dedication and expertise.
This award acknowledges Rick’s profound impact on the field of chemistry and underscores his status as a luminary in the industry.
